1. Home
  2. BIAF vs LIQT Comparison

BIAF vs LIQT Comparison

Compare BIAF & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • LIQT
  • Stock Information
  • Founded
  • BIAF 2014
  • LIQT 2004
  • Country
  • BIAF United States
  • LIQT Denmark
  • Employees
  • BIAF N/A
  • LIQT N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LIQT Industrial Machinery/Components
  • Sector
  • BIAF Health Care
  • LIQT Technology
  • Exchange
  • BIAF Nasdaq
  • LIQT Nasdaq
  • Market Cap
  • BIAF 14.5M
  • LIQT 16.9M
  • IPO Year
  • BIAF 2022
  • LIQT N/A
  • Fundamental
  • Price
  • BIAF $0.67
  • LIQT $1.74
  • Analyst Decision
  • BIAF Strong Buy
  • LIQT Strong Buy
  • Analyst Count
  • BIAF 1
  • LIQT 2
  • Target Price
  • BIAF $6.00
  • LIQT $4.60
  • AVG Volume (30 Days)
  • BIAF 298.9K
  • LIQT 18.1K
  • Earning Date
  • BIAF 11-14-2024
  • LIQT 11-14-2024
  • Dividend Yield
  • BIAF N/A
  • LIQT N/A
  • EPS Growth
  • BIAF N/A
  • LIQT N/A
  • EPS
  • BIAF N/A
  • LIQT N/A
  • Revenue
  • BIAF $9,367,785.00
  • LIQT $15,128,295.00
  • Revenue This Year
  • BIAF $285.51
  • LIQT N/A
  • Revenue Next Year
  • BIAF $20.05
  • LIQT $31.19
  • P/E Ratio
  • BIAF N/A
  • LIQT N/A
  • Revenue Growth
  • BIAF 2813.87
  • LIQT N/A
  • 52 Week Low
  • BIAF $0.64
  • LIQT $1.51
  • 52 Week High
  • BIAF $3.62
  • LIQT $3.55
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 26.36
  • LIQT 43.38
  • Support Level
  • BIAF $0.64
  • LIQT $1.74
  • Resistance Level
  • BIAF $1.01
  • LIQT $1.87
  • Average True Range (ATR)
  • BIAF 0.07
  • LIQT 0.12
  • MACD
  • BIAF -0.01
  • LIQT -0.01
  • Stochastic Oscillator
  • BIAF 5.99
  • LIQT 0.00

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.

Share on Social Networks: